Patent · US Expired

Inhibitors of cyclin-dependent kinases, compositions and uses related thereto

US7605175B2 · kind B2 · utility

0Cited by
10References
26Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 7, 2004
Grant dateOct 20, 2009
Priority date
Expiry dateApr 22, 2026

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2500/10
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The invention pertains to novel cyclin dependent kinase inhibitors (cdks) and specifically, but not exclusively, as inhibitors of cdk/cyclin complexes. As described herein, the inhibitors of this invention are capable of inhibiting the cell-cycle machinery and consequently may be useful in modulating cell-cycle progression, ultimately controlling cell growth and differentiation. Such compounds would be useful for treating subjects having disorders associated with excessive cell proliferation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.